Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer. (Q42961436)
Jump to navigation
Jump to search
scientific article published on 22 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer. |
scientific article published on 22 July 2010 |
Statements
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer (English)
H Wildiers
C Fontaine
P Vuylsteke
M Martens
J L Canon
W Wynendaele
C Focan
P Squifflet